Literature DB >> 21352748

Incongruent HIV and tuberculosis co-dynamics in Kenya: interacting epidemics monitor each other.

María S Sánchez1, James O Lloyd-Smith, Brian G Williams, Travis C Porco, Sadie J Ryan, Martien W Borgdorff, John Mansoer, Christopher Dye, Wayne M Getz.   

Abstract

OBJECTIVE: Kenya is heralded as an example of declining HIV in Africa, while its tuberculosis (TB) numbers continue rising. We conducted a comparative investigation of TB-HIV co-dynamics in Africa to determine the likelihood of reported trends. METHODS AND
RESULTS: Our mathematical modeling analysis exposes the notable incongruence of reported trends in Kenya because TB-HIV co-dynamics, tightly knit worldwide and most dramatically in sub-Saharan Africa, suggest that declining HIV trends should trigger reductions in TB trends. Moreover, a continental-scale analysis of TB-HIV trends places Kenya as an outlier in eastern and southern Africa, and shows TB outpacing HIV in western central Africa. We further investigate which TB processes across HIV stages have greater potential to reduce TB incidence via a sensitivity analysis.
CONCLUSIONS: There are two parsimonious explanations: an unaccounted improvement in TB case detection has occurred, or HIV is not declining as reported. The TB-HIV mismatch could be compounded by surveillance biases due to spatial heterogeneity in disease dynamics. Results highlight the need to re-evaluate trends of both diseases in Kenya, and identify the most critical epidemiological factors at play. Substantial demographic changes have occurred in Kenya, including rapid urbanization accompanied by poor living conditions, which could disproportionately increase TB incidence. Other possible contributors include immune reconstitution due to the recent delivery of antiretrovirals, and an increased presence of the virulent Beijing/W TB genotype. Results support the importance of integrating information from closely interacting epidemics, because this approach provides critical insights unobtainable when components of generalized epidemics are considered individually.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 21352748     DOI: 10.1016/j.epidem.2008.08.001

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  6 in total

1.  Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.

Authors:  David W Dowdy; Jonathan E Golub; Valeria Saraceni; Lawrence H Moulton; Solange C Cavalcante; Silvia Cohn; Antonio G Pacheco; Richard E Chaisson; Betina Durovni
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

2.  Bayesian hierarchical modeling of joint spatiotemporal risk patterns for Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) in Kenya.

Authors:  Verrah A Otiende; Thomas N Achia; Henry G Mwambi
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

3.  Transmission ecology of canine parvovirus in a multi-host, multi-pathogen system.

Authors:  Abdelkader Behdenna; Tiziana Lembo; Olga Calatayud; Sarah Cleaveland; Jo E B Halliday; Craig Packer; Felix Lankester; Katie Hampson; Meggan E Craft; Anna Czupryna; Andrew P Dobson; Edward J Dubovi; Eblate Ernest; Robert Fyumagwa; J Grant C Hopcraft; Christine Mentzel; Imam Mzimbiri; David Sutton; Brian Willett; Daniel T Haydon; Mafalda Viana
Journal:  Proc Biol Sci       Date:  2019-03-27       Impact factor: 5.349

Review 4.  How can mathematical models advance tuberculosis control in high HIV prevalence settings?

Authors:  R M G J Houben; D W Dowdy; A Vassall; T Cohen; M P Nicol; R M Granich; J E Shea; P Eckhoff; C Dye; M E Kimerling; R G White
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

5.  Monitoring linked epidemics: the case of tuberculosis and HIV.

Authors:  María S Sánchez; James O Lloyd-Smith; Wayne M Getz
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

6.  Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya.

Authors:  Verrah Otiende; Thomas Achia; Henry Mwambi
Journal:  BMC Infect Dis       Date:  2019-10-28       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.